New Delhi: Diagnosing ovarian cancer willnow become easier in the country as a lab here is going tointroduce a cost effective and non-surgical method forevaluation of a ovarian mass for cancer. OVA1 test -- the first blood test cleared by the US Foodand Drug Administration -- will soon be introduced by QuestDiagnostics which promises to help in the pre-surgicalevaluation of a woman`s ovarian mass. Ovarian cancer is a silent killer because its symptomsare very nondescript. Under normal circumstances, a physiciancannot know if an ovarian mass is caused by cancer until sheoperates and tests it.
The test utilizes five well-established biomarkers andproprietary software to determine the likelihood of malignancyin women with ovarian mass for whom surgery is planned. Vermillion Inc., a molecular diagnostics company,developed the test in cooperation with Quest Diagnostics. However, Dr Eric T. Fung chief scientific officer withVermillion cautioned, "OVA1 test is only for those above 18years of age. This test should not be utilised as a screeningtest. It should be used when the physician`s independentclinical and radiological evaluation does not indicatemalignancy." PTI
Malaysia Airlines plane crashed off Vietnam coast
Yogendra Yadav`s face smeared with ink
LS polls: Yeddy to contest from Shimoga
Kingfisher women employees say shame on Vijay Mallya